TABLE 1.
Bacterial strains used in this study
| Bacterial strain | Presence of BCESMa | Source, locationb | Referencec |
|---|---|---|---|
| Genomovar I | |||
| C9139 | − | CF, Canada | This study |
| ATCC 25416 | − | Onion, U.S. | 22 |
| ATCC 17759 | − | Soil, Trinidad | 22 |
| ATCC 10856 | − | Onion | ATCC |
| CEP509 | − | CF, Australia | 22 |
| LMG 17997 | − | UTI, Sweden | 22 |
| Genomovar II (B. multivorans) | |||
| C5274 | − | CF, Canada | This study |
| C5393 | − | CF, Canada | 22 |
| 249-2 | − | Laboratory, U.S. | 22 |
| ATCC 17616 | − | Soil, U.S. | 22 |
| C1576 | − | CF-e, U.K. | 22 |
| JTC | − | CGD, U.S. | 22 |
| LMG 13010 | − | CF, Belgium | 22 |
| C1962 | − | Clinic, U.K. | 22 |
| CF-A1-1 | − | CF-e, U.K. | 22 |
| Genomovar III-A | |||
| C1257 | + | CF, Canada | This study |
| C4455 | + | CF, Canada | This study |
| C5424 | + | CF-e, Canada | 22 |
| C6433 | + | CF-e, Canada | 22 |
| J2315 | + | CF-e, U.K. | 22 |
| BC7 | + | CF-e, Canada | 22 |
| K56-2 | + | CF-e, Canada | 22 |
| Genomovar III-B | |||
| PC184 | + | CF-e, U.S. | 22 |
| C1394 | + | CF-e, U.K. | 22 |
| J415 | − | CF, U.K. | 22 |
| CEP511 | + | CF-e, Australia | 22 |
| ATCC 17765 | + | UTI, U.K. | 22 |
| Genomovar IV (B. stabilis) | |||
| C7322 | − | CF, Canada | 22 |
| ATCC 35254 | − | Disinfectant, U.S. | 4 |
| LMG 07000 | − | Clinical, Sweden | BCCM/LMG |
| LMG 14294 | − | CF, Belgium | 22 |
| LMG 14086 | − | Respirator, U.K. | 22 |
| LMG 18888 | − | Clinical, Belgium | 22 |
| Genomovar V (B. vietnamiensis) | |||
| C2822 | − | CF, Canada | This study |
| C9178 | − | CF, Canada | This study |
| PC259 | − | CF, U.S. | 22 |
| LMG 10929 | − | Rice, Vietnam | 22 |
| FC441 | − | CGD, Canada | 22 |
| LMG 16232 | − | CF, Sweden | 22 |
| G4 | − | WTF holding pond, U.S. | 25 |
a
Presence (+) or absence (−) of B. cepacia epidemic strain marker (23).
b
CF, infection of a CF patient; CF-e, strain that has spread epidemically among patients with CF; CGD, infection of a chronic granulomatous disease patient; UTI, urinary tract infection; WTF, waste treatment facility; U.S., United States; U.K., United Kingdom
c
ATCC, American Type Culture Collection, Manassas, Va.; BCCM/LMG, Belgian Co-ordinated Collections of Micro-organisms—Bacteria Collection, Ghent, Belgium.